期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

TRAIL受体在前列腺癌组织中的表达和意义 被引量：3

原文传递
导出
作者 陈朝晖 肖亚军 陈晓春
机构地区 华中科技大学同济医学院附属协和医院泌尿外科
出处 《中华泌尿外科杂志》 CAS CSCD 北大核心 2003年第2期142-142,共1页 Chinese Journal of Urology
基金 国家自然科学基金资助项目( 30 0 70 75 6)
关键词 TRAIL 前列腺癌 表达 意义
分类号 R737.25 [医药卫生—肿瘤]
  • 相关文献

参考文献5

  • 1Pan GH;O'Rourke K;Arul M.The receptor for the cytotoxicity ligend TRAIL[J],1997(5309).
  • 2Pan G;Ni G;Wei YF;Ni J,Yu G.An antagonist decoy receptor and a death domain-containing receptor for TRAIL[J],1997(5327).
  • 3朱迅,刘彦信,马正宇,郑德先.sTRAIL在大肠杆菌中的表达及其诱导细胞凋亡活性的研究[J].科学通报,1999,44(9):972-975. 被引量：8
  • 4Nimmanapalli R;Perkins CL;rlando M.Pretreatment with paclitaxel enhances apo-2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate cancer cells by inducing death receptors 4 and 5 protein levels[J],2001.
  • 5Nagane M;Pan GH;Weddle J.Increased death receptor 5 expression by chemotherapeutic agents in human gliomas causes synergistic cytotoxicity with tumor necrosis factor-related apoptosis-inducing ligand in vitro and in vivo[J],2000.

二级参考文献3

  • 1保亦平 刘彦信 等.CD3ε胞浆区两个酷氨酸共同介导T淋巴细胞调亡[J].科学通报,1998,43(1):1-6.
  • 2何亦平，科学通报，1998年，43卷，1期，1页
  • 3Pan G，Science，1997年，276卷，111页

共引文献9

同被引文献21

  • 1蔡明江,殷玉华,姬秋和,张南雁,黄威权.促性腺素释放激素受体与凋亡相关蛋白FAS在前列腺肿瘤中的共表达及意义[J].解剖学杂志,2004,27(3):263-265. 被引量：1
  • 2Wiley SR, Schooley K,Smolak PJ,et al. Identification and characterization of a New Member of the TNF family that induces Apoptosin. Immunity, 1995,3:673-682
  • 3Fukuda M, Hammao A, Tanaka A, et al. Tumor necrosis factor-related apoptosio-inducing ligand(TRAIL/Apo2L) and its receptors expression in Human squamons all carcinoma of the oral cavity. Oncol Rep, 2003,10(5):1113-1119
  • 4Schally AV,Comaru Schally AM.Rational use of agonists and antagonists of luteinizing hormone-releasing hormone (LHRH) in the treatment of hormone-sensitive neoplasms and gynaecologic conditions.Adu Drug Deliv Rev,1997,28(1):157-169
  • 5Comaru Schally AM,Brannan W,Schally AV,et al. Efficacy and safety of luteinizing hormone-releasing hormone antagonist Cetrorelix in the treatment of symptomatic benign prostatic hyperplasia.J Clin Endocrinol metab,1998,83(11):3826-3831
  • 6Marsters SA, Pitti RA,Sheridan JP, et al. Control of apoptosis signaling by APO-2 ligand. Recent Prog Horm Res,1999,54:225-234
  • 7Hu WH, Johnson H, Shu HB, ET AL.Tumor necrosis factor-related apoptosis-inducing ligand receptors signal NF-κB and JNK activation and apoptosis through distinct pathway. J Biol Chem,1999,274(43):30603
  • 8Kin KH, Fisher MJ, Xu SQ, et al. Molecular determinants of response to TRAIL in killing of normal and cancer cells. Clinical Cancer Research, 2000, 6: 335-346
  • 9Pan G,OcRourke K,Chinnaiyan AM,et al.The receptor for the cytotoxic ligand TRAIL.Science,1997,276(4):111-113.
  • 10Pitti RM,Marsters SA,Ruppert S,et al.Induction of apoptosis by Apo-ligand,a new member of the tumor necrosis factor cytokine family.Biol Chem,1996,271(20):12687-12690.

引证文献3

二级引证文献3

中华泌尿外科杂志
2003年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部